Stockscreener 앱 받기
33.49
0.15%
0.05
Vtv Therapeutics Inc 주식(VTVT)의 최신 뉴스
Technical Reactions to VTVT Trends in Macro Strategies - Stock Traders Daily
MSN Money - MSN
vTv Therapeutics lures two employees with 12,500 stock options - Stock Titan
vTv Therapeutics Shareholders Approve Directors, Question Executive Pay - The Globe and Mail
Trading the Move, Not the Narrative: (VTVT) Edition - Stock Traders Daily
Rodman & Renshaw initiates vTv Therapeutics stock with buy rating By Investing.com - Investing.com Nigeria
Rodman & Renshaw initiates vTv Therapeutics stock with buy rating - Investing.com
Enterprise value to EBITDA forward of vTv Therapeutics Inc. – NASDAQ:VTVT - TradingView
6,000 vTv Therapeutics (VTVT) options granted to director tied to Baker funds - Stock Titan
Form 4 vTv Therapeutics Inc For: 29 June By Investing.com - Investing.com India
[8-K] vTv Therapeutics Inc. Reports Material Event - Stock Titan
vTv Therapeutics (VTVT) director granted 6,000 stock options at $35.08 - Stock Titan
Director at vTv Therapeutics (VTVT) awarded 6,000 stock options grant - Stock Titan
Director at vTv Therapeutics (VTVT) receives 6,000 stock options grant - Stock Titan
Director Fahed Al-Marzooqi (VTVT) granted 6,000 vTv Therapeutics stock options - Stock Titan
Enterprise value to revenue forward of vTv Therapeutics Inc. – NASDAQ:VTVT - TradingView
Price to earnings forward of vTv Therapeutics Inc. – NASDAQ:VTVT - TradingView
Price to book forward of vTv Therapeutics Inc. – NASDAQ:VTVT - TradingView
Price to sales forward of vTv Therapeutics Inc. – NASDAQ:VTVT - TradingView
vTv Therapeutics Q1 2026 Earnings: EPS Surges to $1.94, Driven by Significant SurpriseEPS Miss Report - dars.gov.et
vTv Therapeutics (VTVT) AGM 2026 Summary - Quartr
VTVT: Directors and auditor were approved, but executive compensation was not - TradingView
vTv Therapeutics Inc Annual Shareholders Meeting Transcript - GuruFocus
vTv Therapeutics, Inc. Class A Actuals & Estimates (NASDAQ:VTVT) - TradingView
VTVT Forecast — Price Target — Prediction for 2027 - TradingView
vTv Therapeutics Inc. (VTVT) Q1 2026 Earnings: Massive EPS Surprise Driven by Non-Recurring ItemsEarnings Momentum Score - dars.gov.et
vTv Therapeutics Inc (VTVT) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
vTv Therapeutics Inc (VTVT) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
(VTVT) Volatility Zones as Tactical Triggers - Stock Traders Daily
vTv Therapeutics Inc. Stock 12‑Month Price Target Raised to $54.8, Implies 56% Upside - TradingView
cAMPfield Launches With $180 Million Series A to Advance Prifemilast, a Potential Best-in-Class Oral Therapy for IBD - Yahoo Finance
vTv Therapeutics Inc (VTVT) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
vTv Therapeutics Inc (VTVT) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
vTv Therapeutics Inc (VTVT) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
vTv Therapeutics Inc (VTVT) Institutional Confidence - TradingKey
vTv Therapeutics Inc (VTVT) Valuation: PE, PB & Fair Value Analysis - TradingKey
vTv Therapeutics Inc (VTVT) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
vTv Therapeutics Inc (VTVT) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
VTVT Q1 2026 Earnings: Surprise Profit Amid No RevenueEarnings Preview - newsline.com
Price-Driven Insight from (VTVT) for Rule-Based Strategy - Stock Traders Daily
vTv Therapeutics, Inc. Class A Financial Disclosures & SEC Filings - TradingView
VTVT Q1 2026 Earnings: Massive EPS Beat Driven by Non-Operational ItemsForward EPS Estimate - newsline.com
VTVT Technical Analysis | Trend, Signals & Chart Patterns | VTV THERAPEUTICS INC- CL A (NASDAQ:VTVT) - ChartMill
vTv Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
Stock options, 10-year term: inside vTv Therapeutics grant - Stock Titan
VTVT Stock Price, Quote & Chart | VTV THERAPEUTICS INC- CL A (NASDAQ:VTVT) - ChartMill
vTv Therapeutics Drops as Diabetes Study Date Approaches - Bez Kabli
vTv Therapeutics (VTVT) Edges Lower, Holding Above Key Support Amid ConsolidationRisk Parity Rebalance - thelegaladvocate.com
(VTVT) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
vTv Therapeutics Inc. (VTVT) Edges Lower Amid Consolidation Near SupportComposite Profile - dars.gov.et
VTVT Q1 2026 Earnings: Massive EPS Surprise Driven by a Non-Recurring GainEarnings Quality Score - The Legal Advocate
H.C. Wainwright Sticks to Their Buy Rating for vTv Therapeutics (VTVT) - The Globe and Mail
VTVTvTv Therapeutics Inc Stock Price and Quote - Finviz
H.C. Wainwright Maintains VTv Therapeutics(VTVT.US) With Buy Rating, Maintains Target Price $45 - Moomoo
VTVT Q1 2026 Earnings: Massive EPS Beat Driven by One-Time Items, Stock DeclinesCEO Earnings Statement - The Legal Advocate
vTv Therapeutics Inc. (VTVT) Slips 3% as Resistance Holds; Traders Eye Support TestValue ETF - dars.gov.et
vTv Therapeutics Q1 2026 Earnings: Massive EPS Surprise on One-Time Gains, Shares SlipProfit Margin Analysis - newsline.com
vTv Therapeutics Inc. Q1 2026 Earnings: Massive EPS Surprise Amid Revenue Shortfall and Stock DeclineEBITDA Estimate Trend - The Legal Advocate
vTv Therapeutics Inc. (VTVT) Q1 2026 Earnings: Massive EPS Surprise Despite No RevenueAnalyst Stock Picks - Newser
VTVT | vTv Therapeutics Inc. Class Insider Trading - Quiver Quantitative
2.64%
자본화:
|
볼륨(24시간):